# GLADSTONE LAND Corp: financial statements, quarterly

LAND · Nasdaq · CIK 1495240 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/land.md) · [Financials](/companies/land/financials.md) · [Filings](/companies/land/filings.md) · [Insiders](/companies/land/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/land/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [23.5](/filings/0001495240-24-000028.md) | [(65.9) d](/filings/0001495240-26-000011.md) | [20.3](/filings/0001495240-25-000012.md) | [21.3](/filings/0001495240-25-000021.md) | [22.6](/filings/0001495240-25-000028.md) | [(64.1) d](/filings/0001495240-26-000011.md) | [0.0](/filings/0001495240-26-000016.md) | [0.0](/filings/0001495240-26-000021.md) | [17.8](/filings/0001495240-25-000028.md) | [(34.7) d](/filings/0001495240-26-000011.md) | [1.7](/filings/0001495240-26-000016.md) | [0.3](/filings/0001495240-26-000021.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [5.9](/filings/0001495240-23-000027.md) | [5.8 d](/filings/0001495240-24-000004.md) | [5.6](/filings/0001495240-24-000013.md) | [5.5](/filings/0001495240-25-000021.md) | [5.4](/filings/0001495240-25-000028.md) | [5.4 d](/filings/0001495240-26-000011.md) | [5.2](/filings/0001495240-26-000016.md) | [5.0](/filings/0001495240-26-000021.md) | [4.9](/filings/0001495240-25-000028.md) | [5.0 d](/filings/0001495240-26-000011.md) | [4.7](/filings/0001495240-26-000016.md) | [4.7](/filings/0001495240-26-000021.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001495240-26-000016.md) | [0.0](/filings/0001495240-26-000021.md) | not reported | not reported | [0.0](/filings/0001495240-26-000016.md) | [0.0](/filings/0001495240-26-000021.md) |
| Net income | $m | [3.1](/filings/0001495240-24-000028.md) | [1.8 d](/filings/0001495240-26-000011.md) | [13.6](/filings/0001495240-25-000012.md) | [(0.8)](/filings/0001495240-25-000021.md) | [0.0](/filings/0001495240-25-000028.md) | [0.5 d](/filings/0001495240-26-000011.md) | [15.1](/filings/0001495240-26-000016.md) | [(7.9)](/filings/0001495240-26-000021.md) | [2.1](/filings/0001495240-25-000028.md) | [4.2 d](/filings/0001495240-26-000011.md) | [(4.3)](/filings/0001495240-26-000016.md) | [(8.5)](/filings/0001495240-26-000021.md) |
| Diluted EPS | $ per share | [(0.08)](/filings/0001495240-24-000028.md) | not reported | [0.21](/filings/0001495240-25-000012.md) | [(0.19)](/filings/0001495240-25-000021.md) | [(0.16)](/filings/0001495240-25-000028.md) | not reported | [0.25](/filings/0001495240-26-000016.md) | [(0.38)](/filings/0001495240-26-000021.md) | [(0.11)](/filings/0001495240-25-000028.md) | not reported | [(0.24)](/filings/0001495240-26-000016.md) | [(0.32)](/filings/0001495240-26-000021.md) |
| Basic EPS | $ per share | [(0.08)](/filings/0001495240-24-000028.md) | not reported | [0.21](/filings/0001495240-25-000012.md) | [(0.19)](/filings/0001495240-25-000021.md) | [(0.16)](/filings/0001495240-25-000028.md) | not reported | [0.25](/filings/0001495240-26-000016.md) | [(0.38)](/filings/0001495240-26-000021.md) | [(0.11)](/filings/0001495240-25-000028.md) | not reported | [(0.24)](/filings/0001495240-26-000016.md) | [(0.32)](/filings/0001495240-26-000021.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [25.1](/filings/0001495240-23-000027.md) | [18.6](/filings/0001495240-25-000005.md) | [51.6](/filings/0001495240-24-000013.md) | [49.8](/filings/0001495240-24-000020.md) | [13.2](/filings/0001495240-24-000028.md) | [18.3](/filings/0001495240-26-000011.md) | [42.9](/filings/0001495240-25-000012.md) | [30.5](/filings/0001495240-25-000021.md) | [11.3](/filings/0001495240-25-000028.md) | [27.2](/filings/0001495240-26-000021.md) | [8.6](/filings/0001495240-26-000016.md) | [22.6](/filings/0001495240-26-000021.md) |
| Total assets | $m | [1,406](/filings/0001495240-23-000027.md) | [1,387](/filings/0001495240-25-000005.md) | [1,364](/filings/0001495240-24-000013.md) | [1,353](/filings/0001495240-24-000020.md) | [1,318](/filings/0001495240-24-000028.md) | [1,312](/filings/0001495240-26-000011.md) | [1,282](/filings/0001495240-25-000012.md) | [1,259](/filings/0001495240-25-000021.md) | [1,226](/filings/0001495240-25-000028.md) | [1,239](/filings/0001495240-26-000021.md) | [1,204](/filings/0001495240-26-000016.md) | [1,192](/filings/0001495240-26-000021.md) |
| Total liabilities | $m | [675](/filings/0001495240-23-000027.md) | [668](/filings/0001495240-25-000005.md) | [640](/filings/0001495240-24-000013.md) | [644](/filings/0001495240-24-000020.md) | [627](/filings/0001495240-24-000028.md) | [625](/filings/0001495240-26-000011.md) | [592](/filings/0001495240-25-000012.md) | [589](/filings/0001495240-25-000021.md) | [564](/filings/0001495240-25-000028.md) | [569](/filings/0001495240-26-000021.md) | [515](/filings/0001495240-26-000016.md) | [519](/filings/0001495240-26-000021.md) |
| Long-term debt | $m | [584](/filings/0001495240-23-000027.md) | [574](/filings/0001495240-25-000005.md) | [552](/filings/0001495240-24-000013.md) | [549](/filings/0001495240-24-000020.md) | [531](/filings/0001495240-24-000028.md) | [528](/filings/0001495240-26-000011.md) | [499](/filings/0001495240-25-000012.md) | [496](/filings/0001495240-25-000021.md) | [480](/filings/0001495240-25-000028.md) | [474](/filings/0001495240-26-000021.md) | [484](/filings/0001495240-26-000016.md) | [486](/filings/0001495240-26-000021.md) |
| Shareholders' equity | $m | [731](/filings/0001495240-23-000027.md) | [720](/filings/0001495240-26-000011.md) | [723](/filings/0001495240-25-000021.md) | [708](/filings/0001495240-25-000028.md) | [691](/filings/0001495240-25-000028.md) | [687](/filings/0001495240-26-000021.md) | [690](/filings/0001495240-26-000021.md) | [670](/filings/0001495240-26-000021.md) | [662](/filings/0001495240-25-000028.md) | [670](/filings/0001495240-26-000021.md) | [688](/filings/0001495240-26-000021.md) | [673](/filings/0001495240-26-000021.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.1 d](/filings/0001495240-24-000028.md) | [17.4 d](/filings/0001495240-26-000011.md) | [3.4](/filings/0001495240-25-000012.md) | [15.9 d](/filings/0001495240-25-000021.md) | [(1.4) d](/filings/0001495240-25-000028.md) | [11.6 d](/filings/0001495240-26-000011.md) | [4.5](/filings/0001495240-26-000016.md) | [3.9 d](/filings/0001495240-26-000021.md) | [(12.0) d](/filings/0001495240-25-000028.md) | [10.6 d](/filings/0001495240-26-000011.md) | [9.3](/filings/0001495240-26-000016.md) | [19.9 d](/filings/0001495240-26-000021.md) |
| Dividends paid | $m | [5.0 d](/filings/0001495240-24-000028.md) | [5.0 d](/filings/0001495240-26-000011.md) | [5.0](/filings/0001495240-25-000012.md) | [5.0 d](/filings/0001495240-25-000021.md) | [5.0 d](/filings/0001495240-25-000028.md) | [5.1 d](/filings/0001495240-26-000011.md) | [5.1](/filings/0001495240-26-000016.md) | [5.1 d](/filings/0001495240-26-000021.md) | [5.1 d](/filings/0001495240-25-000028.md) | [5.3 d](/filings/0001495240-26-000011.md) | [5.8](/filings/0001495240-26-000016.md) | [6.0 d](/filings/0001495240-26-000021.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [34.6](/filings/0001495240-23-000027.md) | [35.5](/filings/0001495240-24-000013.md) | [35.7](/filings/0001495240-24-000020.md) | [35.8](/filings/0001495240-24-000028.md) | [35.8](/filings/0001495240-25-000012.md) | [35.8](/filings/0001495240-25-000021.md) | [35.8](/filings/0001495240-25-000028.md) | [36.2](/filings/0001495240-26-000016.md) | [36.2](/filings/0001495240-26-000021.md) | [36.2](/filings/0001495240-25-000028.md) | [40.9](/filings/0001495240-26-000016.md) | [42.9](/filings/0001495240-26-000021.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 43,136,573 at 2026-08-10, from the cover of the [10-Q filed 2026-08-11](/filings/0001495240-26-000021.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.